![](/img/cover-not-exists.png)
Randomized, Placebo-controlled Trial of Rifaximin Therapy for Lowering Gut-derived Cardiovascular Toxins and Inflammation in Chronic Kidney Disease
Kimber, Cassandra, Zhang, Shiqin, Johnson, Cassandra, West, Raymond E., Prokopienko, Alexander J., Mahnken, Jonathan D., Yu, Alan S., Hoofnagle, Andrew N., Ir, Diana, Robertson, Charles E., Miyazaki,Journal:
Kidney360
DOI:
10.34067/KID.0003942020
Date:
September, 2020
File:
PDF, 1.47 MB
2020